Market Exclusive

STRYKER CORPORATION (NYSE:SYK) Files An 8-K Submission of Matters to a Vote of Security Holders

STRYKER CORPORATION (NYSE:SYK) Files An 8-K Submission of Matters to a Vote of Security Holders

ITEM 5.07

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
At the Companys Annual Meeting of Shareholders held on May 3,
2017, shareholders voted on eight proposals and cast their votes
as follows:
Election of directors:
Shares
Name
For
Against
Abstain
Broker Non-Votes
Howard E. Cox, Jr.
292,157,228
13,939,391
287,204
35,103,571
Srikant M. Datar, Ph.D.
303,767,213
2,341,740
274,870
35,103,571
Roch Doliveux, DVM
304,538,982
1,520,325
324,516
35,103,571
Louise L. Francesconi
302,048,059
3,550,485
785,279
35,103,571
Allan C. Golston
302,414,009
3,641,125
328,689
35,103,571
Kevin A. Lobo
300,028,561
5,773,228
582,034
35,103,571
Andrew K. Silvernail
302,302,955
3,739,358
341,510
35,103,571
Ronda E. Stryker
277,912,560
28,259,980
211,283
35,103,571
Ratification of the appointment of Ernst Young LLP as our
independent registered public accounting firm for 2017:
Shares
For
Against
Abstain
331,914,145
9,267,470
305,779
Approval of the 2011 Long-Term Incentive Plan, as amended
and restated:
Shares
For
Against
Abstain
Broker Non-Votes
293,492,121
12,387,811
503,891
35,103,571
Approval of the 2011 Performance Incentive Plan, as
amended and restated:
Shares
For
Against
Abstain
Broker Non-Votes
298,332,907
7,542,328
508,588
35,103,571
Approval of the 2008 Employee Stock Purchase Plan, as
amended and restated:
Shares
For
Against
Abstain
Broker Non-Votes
304,776,652
1,191,868
415,303
35,103,571
Re-approval of the material terms of the performance
goals under the Executive Bonus Plan:
Shares
For
Against
Abstain
Broker Non-Votes
302,009,437
3,830,245
544,141
35,103,571
Advisory vote to approve named executive compensation:
Shares
For
Against
Abstain
Broker Non-Votes
296,096,705
9,315,184
971,934
35,103,571
Advisory vote on the frequency of future advisory votes
on executive compensation:
Shares
One Year
Two Years
Three Years
Abstain
282,914,938
1,071,889
21,628,621
768,375
The results of the shareholder vote with respect to the frequency
of the advisory vote on executive compensation were consistent
with the recommendation of the Company’s Board of Directors that
such vote be held every year. Accordingly, the Company will hold
an annual advisory say-on-pay vote until the next required vote
on the frequency of shareholder votes on the compensation of
executives.

About STRYKER CORPORATION (NYSE:SYK)
Stryker Corporation (Stryker) is a medical technology company. The Company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries. The Company’s MedSurg segment products consist of surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical), and reprocessed and remanufactured medical devices (Sustainability), as well as other medical device products used in a range of medical specialties. The Company’s Neurotechnology and Spine segment products consist of both neurosurgical and neurovascular devices. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. STRYKER CORPORATION (NYSE:SYK) Recent Trading Information
STRYKER CORPORATION (NYSE:SYK) closed its last trading session 00.00 at 135.96 with 710,565 shares trading hands.

Exit mobile version